ArticleInformatics in medicine unlocked2021

Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach.

Nahid Shahabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.